Stay updated on REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial
Sign up to get notified when there's something new on the REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial page.

Latest updates to the REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a consolidated Locations section listing all study sites by state and updated the revision to v3.3.3, replacing the previous state-by-state location blocks.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedThe standard funding/operating-status notice has been removed from the page.SummaryDifference0.2%

- Check55 days agoChange DetectedLevomecor Inc. was added as the sponsor and Relmada Therapeutics, Inc. was removed; the record now shows 'Last Update Posted (Estimated)'.SummaryDifference0.3%

- Check69 days agoChange DetectedNo substantive changes detected between the two page states; only backend QC updates to study record dates (First Submitted 2021-04-19, Last Update 2025-01-17). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedUpdated to v3.2.0 with a government-status notice; removed v3.1.0.SummaryDifference4%

Stay in the know with updates to REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REL-1017 Adjunct in MDD: Efficacy/Safety Clinical Trial page.